Santa Monica, CA5 Active Studies

Multiple Sclerosis Clinical Trials in Santa Monica, CA

Find 5 actively recruiting multiple sclerosis clinical trials in Santa Monica, CA. Connect with local research sites and explore new treatment options.

5
Active Trials
4
Sponsors
7,546
Enrolling

Recruiting Multiple Sclerosis Studies in Santa Monica

About Multiple Sclerosis Clinical Trials in Santa Monica

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 5 multiple sclerosis clinical trials recruiting participants in Santa Monica, CA. These studies are seeking a combined 7,546 participants. Research is being sponsored by HistoSonics, Inc., Janssen Research & Development, LLC, Natera, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Santa Monica — FAQ

Are there multiple sclerosis clinical trials in Santa Monica?

Yes, there are 5 multiple sclerosis clinical trials currently recruiting in Santa Monica, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Santa Monica?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Monica research site will contact you about next steps.

Are clinical trials in Santa Monica free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Santa Monica studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 5 active trials in Santa Monica are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated July 17, 2026 from ClinicalTrials.gov